Dietary Non-protein Amino Acid AZE as an Environmental Trigger Activating Latent Genetic Susceptibility in C9orf72-ALS Pathogenesis
Chen Chongjiu, Zhanyun Lv, Cui Guangyu, Gong Hui, Hua Jianfeng, Luo Tao, Hongyun Bi, Zhang Xinrui, Qinqin Cui, Zhu Hongying, Guo Xing, Nengyin ShengiD, Chengyong SheniD, Fan DongshengiD, Zhang Ke, Liu Huaqing, Ge BaiiD
Abstract
In human disease, clinical manifestations are not always tightly correlated with genetic etiology. While the GGGGCC (G4C2) hexanucleotide repeat expansion in the C9orf72 gene is the most prevalent genetic cause of ALS, a subset of mutation carriers stays asymptomatic. The molecular mechanisms underlying this incomplete penetrance remain elusive. Here, we identify L-azetidine-2-carboxylic acid (AZE), a dietary non-protein amino acid, as a critical environmental risk factor capable of unmasking latent genetic susceptibility in C9orf72-ALS pathogenesis. Specifically, AZE disrupts the proteasome-mediated clearance of toxic poly-GA dipeptide repeats derived from G4C2 repeats, triggering pronounced neuroinflammation and motor defects in a C9orf72-ALS mouse model that otherwise exhibits minimal phenotypes. Notably, AZE is widely present in the food chain (particularly in sugar beet) and consistently detectable in the postmortem human brains. A significant positive correlation was observed between sugar beet consumption and the incidence of sporadic C9-ALS cases in European nations. Critically, dietary intake of sugar beet juice is sufficient to activate subclinical genetic susceptibility in C9orf72-ALS mice. These findings reveal a direct diet-gene interplay in governing C9orf72-ALS penetrance, and propose dietary restriction of AZE-rich foods as a tangible strategy for genetically susceptible individuals to potentially delay or mitigate this currently incurable disorder.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Astrocyte dysfunction distinguishes monozygotic twin C9orf72 expansion carriers discordant for amyotrophic lateral sclerosis.
Allan Christian Shaw, Iris-Stefania Pasniceanu, … Pamela J. Shaw·bioRxiv·Jul 20, 2026
- C9orf72 ALS-causing mutations lead to nucleoporin Nup107 aggregation and subsequent pathological changes
Saygın Bilican, Yara Nabawi, … David Vı́lchez·bioRxiv·Apr 16, 2025
- Glucose Hypometabolism Prompts RAN Translation and Exacerbates C9orf72-related ALS/FTD Phenotypes
Andrew T. Nelson, M.E. Cicardi, … Davide Trotti·EMBO ReportsPeer-reviewed·Apr 29, 2024
- C9orf72-ALS mutation drives mitophagy impairments in iNeurons
James Lee, Sarah M. Granger, … Heather Mortiboys·bioRxiv·Feb 28, 2025
- Characterization of a C9orf72 Knockout Danio rerio model for ALS and cross-species validation of potential therapeutics screened in Caenorhabditis elegans.
Alexandre Emond, Carl Laflamme, … J. Alex Parker·PLoS ONEPeer-reviewed·Apr 10, 2026
- C9orf72 polyGA knock-in mice exhibit mild motor and proteomic changes consistent with ALS/FTD
Carmelo Milioto, Mireia Carcolé, … Adrian M. Isaacs·bioRxiv·May 30, 2025